DEBOXA for Inoperable NET Liver Metastases
NCT03881306
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Neoplasm Metastasis
Liver
Interventions
DRUG:
D-TACE
Sponsor
Xiangya Hospital of Central South University